In what could be another boost to the use of cannabinoid compounds in pharmaceutical and consumer products, a new study supported by the National Science Foundation (NSF) and recently published in Nature outlines their methods for using yeast as essentially a “powerhouse” for producing TCH, CBD and other cannabinoid type compounds. The sugar (“galactose”) can be converted into what is essentially a brewer’s yeast and then used to generate the prime cannabinoid compound, called cannabigerolic acid, which can be synthesized into its desirable components for all sorts of products and applications. For centuries, yeast has been used to produce alcohol and the process has been borrowed and modified to work for cannabinoid extracts. Some say this will be a more environmentally friendly option for producing CBD and THC than the resources used for growing cannabis and hemp crops.
The specific purpose of this research is, in part, to help catalyze the various businesses belonging to these scientists, focused on beverages, and includes companies as Demetrix Inc.
Read a news feature that appeared in Nature on the study.